AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ENERAQUA TECHNOLOGIES PLC

Board/Management Information Jul 21, 2025

7624_rns_2025-07-21_d4503875-6387-4b1e-a396-bad810e1fada.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7512R

Eneraqua Technologies PLC

21 July 2025

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EU (WITHDRAWAL) ACT 2018. 

21 July 2025

Eneraqua Technologies plc

("Eneraqua", the "Company" or the "Group")

Resignation of Nominated Adviser and Joint Broker

Eneraqua Technologies plc ("Eneraqua Technologies " or the "Company") announces that Panmure Liberum Limited ("Panmure Liberum") has resigned with immediate effect as the Company's Nominated Adviser and Joint Broker under the terms and conditions of its Nominated Adviser and Joint Broker Agreement.

Accordingly, the Company's ordinary shares will remain suspended from trading on AIM, inter alia, pursuant to AIM Rule 1, pending the appointment of a replacement nominated adviser.

If the Company fails to appoint a replacement nominated adviser within one month of today's date, admission of the Company's shares to trading on AIM will be cancelled.

For further information please contact:

Eneraqua Technologies plc

Mitesh Dhanak, Chief Executive Officer

John Samuel, Chief Financial Officer
Via Alma
Singer Capital Markets  (Joint Broker)

Asha Chotai
Tel: 020 7496 3000
Alma Strategic Communication (Financial PR)

Justine James

Andy Bryant

Will Ellis Hancock
Tel: 020 3405 0205

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPUGAMUPAGMR

Talk to a Data Expert

Have a question? We'll get back to you promptly.